avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxf1 | mm10_v2_chr8_+_121084352_121084474 | -0.62 | 5.4e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_68117713 Show fit | 9.72 |
ENSMUST00000112346.2
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
|
chr17_-_12675833 Show fit | 8.41 |
ENSMUST00000024596.8
|
solute carrier family 22 (organic cation transporter), member 1 |
|
chr10_-_41579207 Show fit | 8.22 |
ENSMUST00000095227.3
|
coiled-coil domain containing 162 |
|
chr9_-_48605147 Show fit | 7.09 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
nicotinamide N-methyltransferase |
|
chr15_+_4727175 Show fit | 6.26 |
ENSMUST00000162585.1
|
complement component 6 |
|
chr15_+_4727202 Show fit | 6.12 |
ENSMUST00000161997.1
ENSMUST00000022788.8 |
complement component 6 |
|
chr15_+_4727265 Show fit | 5.97 |
ENSMUST00000162350.1
|
complement component 6 |
|
chr16_+_91269759 Show fit | 5.31 |
ENSMUST00000056882.5
|
oligodendrocyte transcription factor 1 |
|
chr1_-_130661584 Show fit | 5.31 |
ENSMUST00000137276.2
|
complement component 4 binding protein |
|
chr1_-_130661613 Show fit | 5.27 |
ENSMUST00000027657.7
|
complement component 4 binding protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 18.3 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.4 | 15.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.5 | 13.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
2.1 | 8.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 7.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.5 | 6.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 6.7 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.2 | 5.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 5.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 5.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 25.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 21.5 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 9.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 6.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 6.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 6.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.7 | 5.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 4.9 | GO:0014069 | postsynaptic density(GO:0014069) |
0.0 | 4.7 | GO:0005911 | cell-cell junction(GO:0005911) |
0.1 | 4.2 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 17.8 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
3.3 | 13.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
3.6 | 10.8 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.4 | 6.0 | GO:0044548 | S100 protein binding(GO:0044548) |
1.1 | 5.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 5.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 5.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 5.1 | GO:0005178 | integrin binding(GO:0005178) |
0.7 | 4.9 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 4.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 10.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 7.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 6.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 6.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 3.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 3.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 29.9 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 13.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.8 | 10.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 7.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 7.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.4 | 6.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 5.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 4.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 3.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 3.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |